Close Menu
    What's Hot

    Jiahui Health Highlights China’s Growing Role in Global Medical Tourism at WTO Public Forum 2026

    September 18, 2026

    Moscow Fashion Week to Bring Together Emerging Designers from Around the World

    September 18, 2026

    Bayer to Present How it Rebuilt Global Planning with OMP at Gartner Supply Chain Planning Summit 2026

    September 17, 2026
    Tel Aviv GazetteTel Aviv Gazette
    • Automotive
    • Business
    • Entertainment
    • Health
    • Lifestyle
    • Luxury
    • News
    • Sports
    • Technology
    • Travel
    Tel Aviv GazetteTel Aviv Gazette
    Home » Cellebrite Announces Upcoming Investor Events on June 10, 2026
    PR Newswire

    Cellebrite Announces Upcoming Investor Events on June 10, 2026

    June 5, 2026
    Facebook WhatsApp Twitter Pinterest LinkedIn Telegram Tumblr Email Reddit VKontakte

    TYSONS CORNER, Va. and PETAH TIKVA, Israel, June 5, 2026 /PRNewswire/ — Cellebrite DI Ltd. (NASDAQ: CLBT), a global leader in AI-powered Digital Investigative and Intelligence solutions for the public and private sectors, today announced that the Company plans to participate in two upcoming investor events on June 10, 2026.

    (PRNewsfoto/Cellebrite)

    Date:

    June 10, 2026

    Event:

    Cellebrite AI Technology Talk

    Overview:

    A deep dive into AI at Cellebrite – from vulnerability research to internal use and
    the introduction of Genesis, the Company’s new agentic AI platform for
    investigations

    Presentation Time:

    9:00 a.m. ET

    Format:

    Webcast

    Event URL:

    https://investors.cellebrite.com/events/event-details/cellebrite-technology-talk

    Webcast URL:

    https://jp-morgan-tech-talk-with-cellebrite-management-oe-live-jun-2026.open-exchange.net/ 

    Moderated by:

    Brian Essex, CFA, executive director, J.P. Morgan

    Cellebrite executives:

    Shiven Ramji, president, products & technology

    Christopher Wade, chief technology officer

    Evyatar Ramot, head of AI Innovation

    Date:

    June 10, 2026

    Conference:

    Mizuho Technology Conference 2026

    Presentation Time:

    11:15 a.m. ET

    Format:

    Fireside Chat

    Event URL:

    https://investors.cellebrite.com/events/event-details/mizuho-technology-conference-2026

    Webcast URL:

    https://kvgo.com/mizuho/cellebrite-di-ltd-june-2026

    Cellebrite executives:

    David Barter, chief financial officer

    Andrew Kramer, vice president, investor relations & treasury

    About Cellebrite 
    Cellebrite’s (Nasdaq: CLBT) mission is to protect communities, nations and businesses as a global leader in digital investigative and intelligence solutions. More than 7,000 global law enforcement agencies, defense and intelligence organizations and enterprises trust Cellebrite’s AI-powered software portfolio to make forensically sound digital data more accessible and actionable. Cellebrite technology allows customers to accelerate nearly 3 million legally sanctioned investigations annually, enhance sovereign security, elevate operational efficacy and efficiency, and enable advanced mobile research and application security. Available via cloud, on-premises and hybrid deployments, Cellebrite’s technology enables its customers around the globe to advance their missions, elevate public safety and safeguard data privacy. To learn more, visit us at www.cellebrite.com and https://investors.cellebrite.com and find us on social media @Cellebrite.

    Investors Relations
    Andrew Kramer
    Vice President, Investor Relations & Treasury
    investors@cellebrite.com
    +1 973.206.7760

    Media 
    Victor Cooper
    Sr. Director of Corporate Communications + Content Operations
    Victor.cooper@cellebrite.com
    +1 404.804.5910

    Cision View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/cellebrite-announces-upcoming-investor-events-on-june-10-2026-302792142.html

    Related Posts

    Jiahui Health Highlights China’s Growing Role in Global Medical Tourism at WTO Public Forum 2026

    September 18, 2026

    Cellebrite Expands Global Digital Community, ‘The 101’, for Digital Forensics and Investigative Professionals

    September 17, 2026

    CGX&OCR Brings Chinese Innovation to the Global Obstacle Racing Stage

    September 17, 2026

    Lutris Pharma to Present Updated Data from Its Phase 2 Trial of LUT014 Gel for the Treatment of Patients With EGFRI-Induced Acneiform Rash at the EADV Congress

    September 16, 2026

    Nitinotes Announces First EASE™ Clinical Trial Procedures at Fondazione Policlinico Universitario Agostino Gemelli IRCCS in Italy

    September 15, 2026

    Cellebrite CTO Chris Wade to Lead Cellebrite Labs, Sharpening Focus on Mobile Research

    September 14, 2026
    Editor's Pick

    DR Congo Ebola outbreak shows progress amid uneven trends

    September 17, 2026

    Gold prices decline on Federal Reserve rate decision as spot drops

    September 17, 2026

    Nepal floods leave 6,150 missing after nationwide review

    September 17, 2026

    Yankee Stadium tower tests positive in NYC Legionella probe

    September 16, 2026
    © 2026 Tel Aviv Gazette | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.